Tradewinds Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $313K | Buy |
261
+33
| +14% | +$33.7K | 0.06% | 88 |
|
|
2026
Q1 | $210K | Sell |
228
-46
| -17% | -$46.6K | 0.04% | 97 |
|
|
2025
Q4 | $294K | Buy |
274
+6
| +2% | +$5.74K | 0.06% | 87 |
|
|
2025
Q3 | $204K | Buy |
268
+14
| +6% | +$10.4K | 0.05% | 96 |
|
|
2025
Q2 | $198K | Hold |
254
| – | – | 0.05% | 95 |
|
|
2025
Q1 | $210K | Hold |
254
| – | – | 0.06% | 93 |
|
|
2024
Q4 | $196K | Sell |
254
-1
| -0.4% | -$828 | 0.05% | 108 |
|
|
2024
Q3 | $226K | Sell |
255
-15
| -6% | -$13.5K | 0.06% | 82 |
|
|
2024
Q2 | $244K | Buy |
270
+5
| +2% | +$4K | 0.07% | 73 |
|
|
2024
Q1 | $206K | Sell |
265
-35
| -12% | -$24.9K | 0.06% | 70 |
|
|
2023
Q4 | $175K | Hold |
300
| – | – | 0.07% | 56 |
|
|
2023
Q3 | $161K | Hold |
300
| – | – | 0.06% | 54 |
|
|
2023
Q2 | $141K | Hold |
300
| – | – | 0.04% | 66 |
|
|
2023
Q1 | $103K | Buy |
300
+130
| +76% | +$43.8K | 0.03% | 72 |
|
|
2022
Q4 | $62.2K | Buy |
170
+45
| +36% | +$16K | 0.03% | 93 |
|
|
2022
Q3 | $40K | Sell |
125
-25
| -17% | -$7.92K | 0.02% | 120 |
|
|
2022
Q2 | $49K | Sell |
150
-1,519
| -91% | -$456K | 0.02% | 111 |
|
|
2022
Q1 | $478K | Sell |
1,669
-50
| -3% | -$12.9K | 0.08% | 76 |
|
|
2021
Q4 | $475K | Buy |
1,719
+50
| +3% | +$12.7K | 0.07% | 80 |
|
|
2021
Q3 | $386K | Hold |
1,669
| – | – | 0.07% | 81 |
|
|
2021
Q2 | $383K | Buy |
1,669
+4
| +0.2% | +$803 | 0.07% | 79 |
|
|
2021
Q1 | $311K | Hold |
1,665
| – | – | 0.06% | 81 |
|
|
2020
Q4 | $281K | Hold |
1,665
| – | – | 0.06% | 86 |
|
|
2020
Q3 | $246K | Hold |
1,665
| – | – | 0.06% | 89 |
|
|
2020
Q2 | $273K | Hold |
1,665
| – | – | 0.07% | 75 |
|
|
2020
Q1 | $231K | Hold |
1,665
| – | – | 0.07% | 78 |
|
|
2019
Q4 | $219K | Buy |
1,665
+320
| +24% | +$37.1K | 0.07% | 97 |
|
|
2019
Q3 | $150K | Hold |
1,345
| – | – | 0.06% | 100 |
|
|
2019
Q2 | $149K | Hold |
1,345
| – | – | 0.06% | 100 |
|
|
2019
Q1 | $175K | Hold |
1,345
| – | – | 0.06% | 113 |
|
|
2018
Q4 | $156K | Hold |
1,345
| – | – | 0.08% | 108 |
|
|
2018
Q3 | $144K | Hold |
1,345
| – | – | 0.06% | 123 |
|
|
2018
Q2 | $115K | Hold |
1,345
| – | – | 0.05% | 136 |
|
|
2018
Q1 | $104K | Hold |
1,345
| – | – | 0.05% | 142 |
|
|
2017
Q4 | $114K | Hold |
1,345
| – | – | 0.06% | 131 |
|
|
2017
Q3 | $115K | Hold |
1,345
| – | – | 0.06% | 137 |
|
|
2017
Q2 | $111K | Hold |
1,345
| – | – | 0.06% | 135 |
|
|
2017
Q1 | $113K | Hold |
1,345
| – | – | 0.07% | 132 |
|
|
2016
Q4 | $99K | Hold |
1,345
| – | – | 0.07% | 142 |
|
|
2016
Q3 | $108K | Buy |
1,345
+245
| +22% | +$19.6K | 0.08% | 127 |
|
|
2016
Q2 | $87K | Hold |
1,100
| – | – | 0.06% | 145 |
|
|
2016
Q1 | $79K | Sell |
1,100
-160
| -13% | -$12.1K | 0.05% | 171 |
|
|
2015
Q4 | $106K | Buy |
1,260
+160
| +15% | +$13.3K | 0.08% | 143 |
|
|
2015
Q3 | $92K | Hold |
1,100
| – | – | 0.07% | 148 |
|
|
2015
Q2 | $92K | Hold |
1,100
| – | – | 0.06% | 163 |
|
|
2015
Q1 | $80K | Hold |
1,100
| – | – | 0.06% | 168 |
|
|
2014
Q4 | $76K | Hold |
1,100
| – | – | 0.05% | 168 |
|
|
2014
Q3 | $71K | Hold |
1,100
| – | – | 0.05% | 175 |
|
|
2014
Q2 | $68K | Hold |
1,100
| – | – | 0.05% | 188 |
|
|
2014
Q1 | $65K | Hold |
1,100
| – | – | 0.05% | 194 |
|
|
2013
Q4 | $56K | Buy |
+1,100
| New | +$55.1K | 0.05% | 197 |
|
Other funds holding LLY
SC
ONB
GIM
Tradewinds Capital Management's LLY Position: Q2 2026 in Review
Tradewinds Capital Management increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $33.7K and bringing the position to 261 shares worth $313K. The position accounts for 0.06% of the portfolio, ranked #88.
Tradewinds Capital Management first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. The position peaked at $478K in Q1 2022. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Tradewinds Capital Management held 261 shares of Eli Lilly worth $313K as of Q2 2026.
- Tradewinds Capital Management bought 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
- Eli Lilly made up 0.06% of Tradewinds Capital Management's portfolio in Q2 2026, its #88 holding.
- Tradewinds Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
- Tradewinds Capital Management's Eli Lilly position peaked at $478K in Q1 2022.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.